1. Home
  2. EYPT vs ODC Comparison

EYPT vs ODC Comparison

Compare EYPT & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • ODC
  • Stock Information
  • Founded
  • EYPT 1987
  • ODC 1941
  • Country
  • EYPT United States
  • ODC United States
  • Employees
  • EYPT N/A
  • ODC N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • ODC Miscellaneous manufacturing industries
  • Sector
  • EYPT Industrials
  • ODC Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • ODC Nasdaq
  • Market Cap
  • EYPT 439.4M
  • ODC 509.3M
  • IPO Year
  • EYPT 2005
  • ODC N/A
  • Fundamental
  • Price
  • EYPT $9.17
  • ODC $68.17
  • Analyst Decision
  • EYPT Strong Buy
  • ODC
  • Analyst Count
  • EYPT 8
  • ODC 0
  • Target Price
  • EYPT $27.29
  • ODC N/A
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • ODC 16.0K
  • Earning Date
  • EYPT 11-07-2024
  • ODC 12-09-2024
  • Dividend Yield
  • EYPT N/A
  • ODC 0.91%
  • EPS Growth
  • EYPT N/A
  • ODC 31.48
  • EPS
  • EYPT N/A
  • ODC 5.43
  • Revenue
  • EYPT $45,713,000.00
  • ODC $437,587,000.00
  • Revenue This Year
  • EYPT N/A
  • ODC N/A
  • Revenue Next Year
  • EYPT N/A
  • ODC N/A
  • P/E Ratio
  • EYPT N/A
  • ODC $12.54
  • Revenue Growth
  • EYPT 7.50
  • ODC 5.95
  • 52 Week Low
  • EYPT $5.86
  • ODC $54.91
  • 52 Week High
  • EYPT $30.99
  • ODC $87.32
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 38.25
  • ODC 45.90
  • Support Level
  • EYPT $11.26
  • ODC $66.92
  • Resistance Level
  • EYPT $12.23
  • ODC $76.41
  • Average True Range (ATR)
  • EYPT 0.97
  • ODC 2.03
  • MACD
  • EYPT -0.30
  • ODC -0.35
  • Stochastic Oscillator
  • EYPT 3.24
  • ODC 13.12

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: